Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA)

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA), covering 2024-05-16 to 2024-05-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) in Healthy Adult Panelists [Phase 1]

See pricing